×
Pour une meilleure utilisation, nous vous conseillons d’activer Javascript dans votre navigateur.
Ret Proto-Oncogene anticorps (AA 29-300)
RET
Reactivité: Humain
WB, IHC, IF
Hôte: Lapin
Polyclonal
unconjugated
N° du produit ABIN6146873
Détail du produit anti-Ret Proto-Oncogene anticorps
(cache)
Antigène
Voir toutes Ret Proto-Oncogene (RET) Anticorps
Ret Proto-Oncogene (RET)
Épitope
Tous les épitopes à travers Ret Proto-Oncogene Anticorps.
AA 29-300
Reactivité
Toutes les réactivités sur Ret Proto-Oncogene Anticorps
Humain
Hôte
Toutes les hôtes sur Ret Proto-Oncogene Anticorps
Lapin
Clonalité
Toutes les clonalités sur Ret Proto-Oncogene Anticorps
Polyclonal
Conjugué
Tous les conjugués à travers Ret Proto-Oncogene Anticorps
Cet anticorp Ret Proto-Oncogene est non-conjugé
Application
Tous les applications à travers Ret Proto-Oncogene Anticorps.
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
Séquence
LYFSRDAYWE KLYVDQAAGT PLLYVHALRD APEEVPSFRL GQHLYGTYRT RLHENNWICI QEDTGLLYLN RSLDHSSWEK LSVRNRGFPL LTVYLKVFLS PTSLREGECQ WPGCARVYFS FFNTSFPACS SLKPRELCFP ETRPSFRIRE NRPPGTFHQF RLLPVQFLCP NISVAYRLLE GEGLPFRCAP DSLEVSTRWA LDREQREKYE LVAVCTVHAG AREEVVMVPF PVTVYDEDDS APTFPAGVDT ASAVVEFKRK EDTVVATLRV FD
Réactivité croisée
Humain, Souris, Rat
Attributs du produit
Polyclonal Antibodies
Immunogène
Recombinant fusion protein containing a sequence corresponding to amino acids 29-300 of human Ret (NP_066124.1).
Isotype
IgG
Top Product
Discover our top product RET Anticorps primaire
Alternatives
(show)
Information d'application
(cache)
Indications d'application
WB,1:500 - 1:2000,IHC,1:50 - 1:200,IF,1:50 - 1:200
Restrictions
For Research Use only
Stockage
(cache)
Format
Liquid
Buffer
PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C
Stockage commentaire
Store at -20°C. Avoid freeze / thaw cycles.
Détails sur Ret Proto-Oncogene
(cache)
Antigène
Ret Proto-Oncogene (RET)
Autre désignation
RET (RET Produits )
Synonymes
anticorps c-ret, anticorps cret, anticorps etID315074.13, anticorps ret1, anticorps wu:fd13h01, anticorps X-ret, anticorps ret-A, anticorps xret, anticorps RET, anticorps MTC1, anticorps CDHF12, anticorps CDHR16, anticorps HSCR1, anticorps MEN2A, anticorps MEN2B, anticorps PTC, anticorps RET-ELE1, anticorps RET51, anticorps RET9, anticorps c-Ret, anticorps ret proto-oncogene receptor tyrosine kinase, anticorps ret proto-oncogene S homeolog, anticorps ret proto-oncogene, anticorps ret, anticorps ret.S, anticorps RET, anticorps Ret
Sujet
This gene, a member of the cadherin superfamily, encodes one of the receptor tyrosine kinases, which are cell-surface molecules that transduce signals for cell growth and differentiation. This gene plays a crucial role in neural crest development, and it can undergo oncogenic activation in vivo and in vitro by cytogenetic rearrangement. Mutations in this gene are associated with the disorders multiple endocrine neoplasia, type IIA, multiple endocrine neoplasia, type IIB, Hirschsprung disease, and medullary thyroid carcinoma. Two transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their biological validity has not been confirmed.,RET,CDHF12,CDHR16,HSCR1,MEN2A,MEN2B,MTC1,PTC,RET-ELE1,RET51,Cancer,Signal Transduction,Kinase,Tyrosine kinases,Cell Biology & Developmental Biology,Growth factor,RET
Poids moléculaire
119 kDa/124 kDa
ID gène
5979
UniProt
P07949
Pathways
Signalisation RTK , Dopaminergic Neurogenesis , Regulation of Cell Size , Tube Formation
Vus récemment
(cache)